Inhalation

INH1026

Issue link: https://www.e-digitaleditions.com/i/1546950

Contents of this Issue

Navigation

Page 15 of 43

14 OctOber 2026 Inhalation umeclidinium/vilanterol and Foster ® NEXaler ® (beclometasone/formoterol) DPIs. According to both simulation and deposition measurements, decrease of the add-on division wall thickness led to less upper airway deposition and a greater amount of drug entering the lungs. Increase of the division wall thickness resulted in the increase of wall cross-sectional surface. As this surface is per- pendicular to the flow direction, it represented an obstacle for particles to deposit upon. erefore, all these results refer to a 0.2 mm wall thickness. A wall thickness below 0.2 mm could not be reliably reproduced using 3D printing. As expected, the highest add-on efficiency was achieved for the inhalers with high turbulence inten- sity at the mouthpiece. However, for all inhaler-drug pairs, improvements were achieved in the quantity of drug reaching the lungs by the appropriate choice of add-on. In a general observation, the cup-shaped add-ons usually were more efficient at higher tur- bulence levels, while the conical add-ons showed improved performance in cases of less perturbed flows. is is due to the ability of the buffer zone of the cup-shaped add-on to dissipate jets emerging from the mouthpiece. e ideal number of inner divisions depended on the inhaler and flow rate. Table 1 shows the average values of the relative change in the amount (mass) of drug entering the lungs, expressed as a percent of the amount reach- ing the lungs in the absence of add-ons. As the values indicate, the smallest increase was observed for the Ultibro Breezhaler, although even in this case the maximum relative change exceeded 30%. Particle tracking simulations demonstrated that the number of add-on inner walls increased the number of particles escaping the upper airways up to a cer- tain division number. However, a high number of divisions gradually decreased the number of parti- cles penetrating the lungs due to deposition on the inner walls. e six shapes retained for further study based on results of the CFPD calculations were: (1) conical add-on without inner divisions; (2) conical add-on with three inner divisions; (3) conical add-on with four inner divisions; (4) conical add-on with six inner divisions; (5) cup-shaped add-on without inner divisions; and (6) cup-shaped add-on with four inner divisions. According to the simulated values of the upper airway deposition fractions, these shapes proved to enhance the chance that the drug parti- cles would reach the lungs, at least for some of the drugs studied and at some of the flow rates consid- ered. e 3D-printed versions of these shapes can be seen in Figure 4 (right panel). It is worth noting these items have two functional parts. One modulates the flow and the other ensures tight connection with the inhaler mouthpiece, as depicted and explained in two CAD images on the left panel of Figure 4. Further- more, the items prepared for the experimental mea- surements seen in Figure 4 had different inner wall thicknesses ranging between 0.2 and 0.5 mm. Experimental measurements of the efficiency of the proposed add-ons e experimental measurements were performed with the Ultibro ® Breezhaler ® (indacaterol/glyco- pyrronium), Symbicort ® Turbuhaler ® (budesonide/ formoterol), Trelegy ® Ellipta ® (fluticasone furoate/ Figure 4 CAD images of the add-ons (left panel) and a photo of the optimized add-on shapes selected for the experimental deposition measurements (right panel). The names refer to the shape of the add-ons ("cone"' or "cup") and the number of divisions (0, 3, 4 or 6). Mouth Add-on Inhaler mouthpiece Mouth Add-on Inhaler mouthpiece

Articles in this issue

view archives of Inhalation - INH1026